<DOC>
	<DOCNO>NCT01834729</DOCNO>
	<brief_summary>This study design well understand effect effect stress , relaxation , medication alfuzosin bowel control empty healthy people patient bowel problem . Normally , bowel empty require relaxation anal sphincter ( i.e. , lowermost end intestinal tract ) pelvic muscle . Some people relax muscle normally experience constipation . Alfuzosin medication approve treat bladder bowel problem .</brief_summary>
	<brief_title>Effects Alpha-1 Antagonist , Stress Relaxation Anorectal Functions</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>Inclusion criterion control ( Part A ) : Healthy Able provide write informed consent participate study Able communicate adequately investigator comply requirement entire study . Inclusion criterion patient ( Parts A B ) : Women chronic constipation 1 year 2 follow symptom 3 month longer , i.e . &lt; 3 bowel motions/week , strain ≥ 25 % time , hard lumpy stool ≥ 25 % time , incomplete evacuation ≥ 25 % time , feel anorectal blockage ≥ 25 % time . Able provide write informed consent participate study Able communicate adequately investigator comply requirement entire study . Exclusion criterion control ( Part A ) ; Items indicate asterisk ( * ) also exclusion criterion patient ( Parts A B ) : Clinical evidence significant cardiovascular , respiratory , renal , hepatic , gastrointestinal , hematological , neurological , psychiatric disease may interfere objective study and/or pose safety concern . * Current symptomatic orthostatic hypotension history hypotensive response define reduction ≥ 30 mmHg systolic ≥ 20 mmHg diastolic blood pressure . * Current symptom functional gastrointestinal disorder assess questionnaire . Putative risk factor pelvic floor trauma , i.e . six vaginal delivery , birthweight &gt; 4500gms ( macrosomia ) , know 4th degree perineal tear . Inability withdraw medication prior baseline period throughout study ( except protocol define rescue medication ) : 1 . Medications substantially alter GI transit* include laxative , magnesium aluminum contain antacid , prokinetics , erythromycin , narcotic , anticholinergic , tricyclic antidepressant , serotoninnorepinephrine reuptake inhibitor ( SNRI ) new antidepressant 2 . Selective serotonin reuptake inhibitor ( SSRI ) antidepressants permissible low , stable dos . All medication shall review dis/approved principal investigator case case basis . * 3 . Potent Cytochrome P450 3A4 ( Cyp3A4 ) inhibitor ketoconazole , itraconazole ritonavir , nitrate phosphodiesterase inhibitor . * NOTE : stable dos thyroid replacement , estrogen replacement , low dose aspirin cardioprotection , birth control ( adequate backup contraception druginteractions birth control conduct ) permissible . * Stable dose thyroxine permitted* Prolonged QTc interval &gt; 500 msec ECG within last three months* Estimated glomerular filtration rate ( eGFR ) &lt; 60 mL/minute . * Based guideline recommendation National Kidney Disease Education Program ( NKDEP ) National Institutes Health ( NIH ) Kidney Disease Outcomes Quality Initiative ( KDOQI ) National Kidney Foundation , eGFR use Modification Diet Renal Disease ( MDRD ) Study equation accurate creatinine clearance calculate serum urine measurement . The formula eGFR ( mL/min/1.73 m2 ) = 175 x ( Scr ) 1.154 x ( Age ) 0.203 x ( 0.742 female ) x ( 1.210 African American ) . Based extensive experience clinical practice research study , anticipate potentially eligible participant normal serum creatinine . History allergy alpha1 adrenoreceptor antagonist* Active rectal inflammation , cancer ; perianal sepsis ; history pelvic radiation , rectosigmoid surgery inflammatory bowel disease* Pregnant woman , prisoner institutionalize individuals* Persons latex allergy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>